Cost of breast cancer treatment: A 4-year longitudinal study

Archives of Internal Medicine

Volumn 156, Issue 19, 1996, Pages 2197-2201

  Legorreta, Antonio P ^a,b   Brooks, Ronald J ^c   Leibowitz, Arthur N ^c   Solin, Lawrence J ^d  

^a Health Net   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c US Healthcare   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER STAGING; COST BENEFIT ANALYSIS; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITAL COST; MAMMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; COSTS AND COST ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; LONGITUDINAL STUDIES; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; UNITED STATES;

EID: 0029807791     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.19.2197     Document Type: Article

References (29)

1. American Cancer Society. Breast Cancer Facts and Figures, 1996. Atlanta, Ga: American Cancer Society; 1995.
2. Solin LJ, Schultz DJ, Legorreta AP, Goodman RL. Dowristaging of breast carcinomas associated with mammographic screening. Breast Dis. 1995;8:45-56.
3. Solin LJ, Legorreta A, Schultz DJ, Zatz S, Goodman RL. The importance of mammographic screening relative to the treatment of women with carcinoma of the breast. Arch Intern Med. 1994;154:745-752.
4. Brown ML, Fintor L. Cost-effecfiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat. 1993;25:113-118.
5. Eddy DM. Screening for breast cancer. Ann Intern Med. 1989;111:389-399.
6. Solin LJ, Legorreta A, Schultz DJ, Levin HA, Zatz S, Goodman RL. Analysis of a claims database for the identification of patients with carcinoma of the breast. J Med Syst. 1994;18:23-32.
7. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med. 1991;114:657-661.
8. Rimer BK, Davis SW, Engstrom PF, Myers RE, Rosan JR. Some reasons for compliance and noncompliance in a health maintenance organization breast cancer screening program. J Compliance Health Care. 1988;3:103-114.
9. Rimer BK, Keintz MK, Kessler HB, Engstrom PF, Rosan JR. Why women resist screening mammography: patient-related barriers. Radiology. 1989;172:243-246.
10. Rimer BK, Trock B, Engstrom PF, Lerman C, King E. Why do some women get regular mammograms? Am J Prev Med. 1991;7:69-74.
11. Trock B, Rimer BK, King E, Balshem A, Cristirizo CS, Engstrom PF. Impact of an HMO-based intervention to increase mammography utilization. Cancer Epidemiol Biomarkers Prev. 1993;2:151-156.
12. American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed. Philadelphia, Pa: JB Lippincott; 1992:149-154.
13. Fowle B, Goodman RL, Glick JH, Rosato EF, eds. Breast Cancer Treatment: A Comprehensive Guide to Management. St Louis, Mo: Mosby-Year Book Inc; 1991:337-341.
14. Harris JR, Morrow M, Bonadonna G. Cancer of the breast. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia, Pa: JB Lippincott; 1993;1264-1332.
15. US Bureau of Labor Statistics. CPI Detailed Report. Washington, DC: US Bureau of Labor Statistics; 1994.
16. Janjan NA, Naftinger AB, Young M, Wilson JF. First-year treatment charges for early-stage vs locally advanced breast cancer. Breast Dis. 1993;6:23-37.
17. Baker MS, Kessler LG, Urban N, Smucker RC. Estimating the treatment costs of breast and lung cancers. Med Care. 1991;29:40-49.
18. Munoz E, Shamash F, Friedman M, Teicher I, Wise L. Lumpectomy vs mastectomy: the costs of breast preservation for cancer. Arch Surg. 1986;121: 1297-1201.
19. Perez CA. Costs of lumpeciomy vs mastectomy. Arch Surg. 1987;122:736.
20. Moskowitz M. Costs of screening for breast cancer. Radiol Clin North Am. 1987;25:1031-1037.
21. Gerard K, Salkeld G, Hall J. Counting the costs of mammography screening: first-year results from the Sydney Study. Med J Aust. 1990;152:466-471.
22. Eddy MD. Screening for breast cancer. Ann Intern Med. 1989;111:389-399.
23. Forsyth RA. The mathematics of screening mammography. Med Hypotheses. 1988;26:21-24.
24. de Koning HJ, van Ineveld BM, van Oortmarssen GJ, et al. Breast cancer screening and cost-effectiveness: policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer. 1991;49:531-537.
25. Zaverinik JJ, McCoy CB, Robinson DS, Love N. Cost-effective management of breast cancer. Cancer. 1992;69:1979-1984.
26. Miller AB. Cancer screening. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia, Pa: JB Lippincott; 1993:564-573.
27. Schapira DV. Breast cancer surveillance: a cost-effective strategy. Breast Cancer Res Treat. 1993;25:107-111.
28. Hillner BE, Smith TJ, Desch CE. Assessing the cost-effectiveness of adjuvant therapies In early breast cancer using a decision analysis model. Breast Cancer Res Treat. 1993;25:97-105.
29. Hillner BE, Smith TJ, Desch CE. Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer: estimates using decision analysis while awaiting clinical trial results. JAMA. 1992;267:2055-2061.